247 related articles for article (PubMed ID: 668190)
21. Quantitation of immunocompetence in Hodgkin's disease.
Faguet GB
J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte response to pokeweed mitogen in Hodgkin's disease.
Cohnen G; König E; Augener W; Brittinger G
Biomedicine; 1973 Jun; 19(6):239-43. PubMed ID: 4752298
[No Abstract] [Full Text] [Related]
23. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
24. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
25. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
27. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
28. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Nilsson P
J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
[TBL] [Abstract][Full Text] [Related]
29. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
[TBL] [Abstract][Full Text] [Related]
30. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
31. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
33. Normal natural killer cell activity in Hodgkin's disease patients in remission.
Douer D; Shaked N; Ramot B
Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
[TBL] [Abstract][Full Text] [Related]
34. In vitro leukocyte interferon production in patients with Hodgkin's disease.
Rassiga-Pidot AL; McIntyre OR
Cancer Res; 1974 Nov; 34(11):2995-3002. PubMed ID: 4421578
[No Abstract] [Full Text] [Related]
35. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
[No Abstract] [Full Text] [Related]
36. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
Petrov M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
[TBL] [Abstract][Full Text] [Related]
37. Abnormal T-cell activation in chronic hepatitis B viral infection: a consequence of monocyte dysfunction?
Nouri-Aria KT; Magrin S; Alexander GJ; Anderson MG; Williams R; Eddleston AL
Immunology; 1988 Aug; 64(4):733-8. PubMed ID: 2971612
[TBL] [Abstract][Full Text] [Related]
38. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
39. Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism.
Ambrogi F; Grassi B; Ronca-Testoni S; Ronca G
Clin Exp Immunol; 1977 Apr; 28(1):80-8. PubMed ID: 405169
[TBL] [Abstract][Full Text] [Related]
40. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
